Mélanie Ott
- Virology top 0.1%
- HIV Research and Treatment 38
- Geriatrics and Gerontology top 0.1%
- Sirtuins and Resveratrol in Medicine 12
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research 18
- HIV/AIDS drug development and treatment 9
- Hepatology top 1%
- Hepatitis C virus research 15
- Immunology top 1%
- Immune Cell Function and Interaction 10
-
- RNA Research and Splicing 14
- Protein Degradation and Inhibitors 13
Mélanie Ott
134 papers receiving 10.7k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Virology 2.7k
- Geriatrics and Gerontology 1.2k
- Infectious Diseases 2.1k
- Hepatology 686
- Immunology 1.8k
Countries citing papers authored by Mélanie Ott
This map shows the geographic impact of Mélanie Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Ott more than expected).
Fields of papers citing papers by Mélanie Ott
This network shows the impact of papers produced by Mélanie Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Ott. The network helps show where Mélanie Ott may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mélanie Ott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 15 | |
| 5 | 2023 | 31 | |
| 6 | 2022 | 41 | |
| 7 | 2022 | 7 | |
| 8 | 2021 | 130 | |
| 9 | 2021 | 44 | |
| 10 | Rapid assessment of SARS-CoV-2–evolved variants using virus-like particlesbreakdown → | 2021 | 193 |
| 11 | 2021 | 16 | |
| 12 | 2020 | 20 | |
| 13 | 2017 | 97 | |
| 14 | 2017 | 34 | |
| 15 | 2015 | 124 | |
| 16 | 2013 | 95 | |
| 17 | 2011 | 83 | |
| 18 | 2011 | 143 | |
| 19 | 2005 | 47 | |
| 20 | 2005 | 43 |
About Mélanie Ott
Mélanie Ott is a scholar working on Virology, Geriatrics and Gerontology, Infectious Diseases, Hepatology and Biochemistry, having authored 137 papers that have together received 10.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (38 papers), SARS-CoV-2 and COVID-19 Research (18 papers), Hepatitis C virus research (15 papers), RNA Research and Splicing (14 papers), Protein Degradation and Inhibitors (13 papers), Sirtuins and Resveratrol in Medicine (12 papers), Immune Cell Function and Interaction (10 papers) and HIV/AIDS drug development and treatment (9 papers). The work is most often cited by research in Virology (2.7k citations), Geriatrics and Gerontology (1.2k citations), Infectious Diseases (2.1k citations), Hepatology (686 citations) and Immunology (1.8k citations). Mélanie Ott has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Eric Verdin, Stéphane Emiliani, Carine Van Lint, Eva Herker, Katrin Kaehlcke, Hye‐Sook Kwon, Martina Schnölzer, Roy A. Frye, Brian J. North and Ryan J. Conrad. Their work appears in journals such as Journal of Biological Chemistry, Molecular Cell, PLoS Pathogens, Cell Host & Microbe and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.